SB967Introduced in the Senate
Relating To Health.
Introduced by Kurt Fevella, District 20
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Requires Medicaid and private insurance coverage for intravenous ketamine therapy to treat depression. Appropriates moneys.
Where it stands
The committee on HHS deferred the measure.
February 6, 2026
How did lawmakers vote?
No recorded vote is available for this bill yet.
Bill history
Introduced.
Passed First Reading.
Referred to HHS, CPN/WAM.
Carried over to 2026 Regular Session.
The committee(s) on HHS has scheduled a public hearing on 02-06-26 1:00PM; Conference Room 225 & Videoconference.
The committee on HHS deferred the measure.
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.